Steve Medlicott, Finance Director at E Therapeutics, holds 1.55M shares in E Therapeutics (Ticker: GB:ETX). Most recently, Steve Medlicott Bought 100,000p shares of E Therapeutics on Aug 09, 2018 for an estimated value of 7.00K.
What is the percentage of profitable transactions made by Steve Medlicott?
The percentage of profitable transactions made by Steve Medlicott is 40%.
What is the average return per transaction made by Steve Medlicott?
The average return per transaction made by Steve Medlicott is -14.10%.
What stocks does Steve Medlicott hold?
Steve Medlicott holds: GB:ETX stocks.
What was Steve Medlicott’s latest transaction?
Steve Medlicott latest transaction was an Informative Buy of 7.00K.
What was Steve Medlicott's most profitable transaction?
Steve Medlicott’s most profitable transaction was an Informative Buy of GB:ETX stock on July 4, 2014. The return on the trade was 37.20%.
What is Steve Medlicott's role in E Therapeutics?
Steve Medlicott's role in E Therapeutics is Finance Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.